BCL3 Rekombinanter Antikörper

BCL3 Rekombinant Antikörper für IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

242233B11

Kat-Nr. : 84882-5-PBS

Synonyme

242233B11, B-cell lymphoma 3 protein, BCL-3, BCL4, D19S37



Geprüfte Anwendungen

Produktinformation

84882-5-PBS bindet in IHC, IF/ICC, Indirect ELISA BCL3 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen BCL3 fusion protein Ag13375
Vollständiger Name B-cell CLL/lymphoma 3
Berechnetes Molekulargewicht 446 aa, 47 kDa
Beobachtetes Molekulargewicht 48-60 kDa
GenBank-ZugangsnummerBC064993
Gene symbol BCL3
Gene ID (NCBI) 602
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

BCL3 (B-cell lymphoma 3 protein) has seven ankyrin repeat domains, a proline-rich N terminal domain and a serine- and proline-rich C-terminal domain (PMID: 31930327). BCL3 is an important contributor to chronic inflammatory disease states, such as osteoarthritis and rheumatoid arthritis (PMID: 12483727). BCL3 is a predominantly nuclear protein containing a trans-activation domain, and it can be recruited to NF-κB-responsive promoters, resulting in transcriptional activation or repression depending on the subunit composition of NF-κB complexes (PMID: 25089799, PMID: 30135206). BCL3 is known to be overexpressed in human breast cancers and is associated with reduced metastasis-free survival (PMID: 38255248).